Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Intangibles (2020 - 2024)

Cardiol Therapeutics filings provide 3 years of Intangibles readings, the most recent being $217181.5 for Q4 2022.

  • On a quarterly basis, Intangibles rose 170.56% to $217181.5 in Q4 2022 year-over-year; TTM through Dec 2022 was $217181.5, a 170.56% increase, with the full-year FY2022 number at $217181.5, up 170.56% from a year prior.
  • Intangibles hit $217181.5 in Q4 2022 for Cardiol Therapeutics, down from $242225.1 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $342875.7 in Q2 2021 to a low of -$307800.1 in Q4 2021.
  • Median Intangibles over the past 3 years was $253283.4 (2022), compared with a mean of $140847.5.
  • Biggest five-year swings in Intangibles: tumbled 32.2% in 2021 and later soared 170.56% in 2022.
  • Cardiol Therapeutics' Intangibles stood at -$232830.2 in 2020, then plummeted by 32.2% to -$307800.1 in 2021, then soared by 170.56% to $217181.5 in 2022.
  • The last three reported values for Intangibles were $217181.5 (Q4 2022), $242225.1 (Q3 2022), and $264341.6 (Q2 2022) per Business Quant data.